Lupin Recalls Subpotent Generic Oral Contraceptives
Lupin Pharmaceuticals is recalling more than 4,100 cartons of a generic contraceptive tablet distributed in the U.S. over potency problems.
The birth control drug, Tydemy (drospirenone/ethinyl estradiol/levomefolate calcium), was manufactured at the drugmaker’s facility in Madhya Pradesh, India.
This is the company’s second recall in recent months. In October, Lupin recalled all batches of its irbesartan and irbesartan/hydrochlorothiazide tablets supplied in the U.S. over concerns the blood pressure drugs possibly contained N-nitrosoirbesartan, a likely carcinogen.
Lupin could not be reached for comment.